BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19284355)

  • 1. Rationale for blood conservation.
    Goodnough LT
    Surg Infect (Larchmt); 2005; 6 Suppl 1():S3-8. PubMed ID: 19284355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute normovolemic hemodilution.
    Monk TG
    Surg Infect (Larchmt); 2005; 6 Suppl 1():S9-15. PubMed ID: 19284358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of pharmacologic therapies in patient blood management.
    Goodnough LT; Shander A
    Anesth Analg; 2013 Jan; 116(1):15-34. PubMed ID: 23223098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternatives to allogeneic blood use in surgery: acute normovolemic hemodilution and preoperative autologous donation.
    D'Ambra MN; Kaplan DK
    Am J Surg; 1995 Dec; 170(6A Suppl):49S-52S. PubMed ID: 8546248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternatives to allogeneic blood transfusions.
    Pape A; Habler O
    Best Pract Res Clin Anaesthesiol; 2007 Jun; 21(2):221-39. PubMed ID: 17650774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood conservation strategies in major orthopaedic surgery: efficacy, safety and European regulations.
    Muñoz M; García-Erce JA; Villar I; Thomas D
    Vox Sang; 2009 Jan; 96(1):1-13. PubMed ID: 19121192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of acute normovolemic hemodilution in patients undergoing radical prostatectomy.
    Terai A; Terada N; Yoshimura K; Ichioka K; Ueda N; Utsunomiya N; Kohei N; Arai Y; Yonei A
    Urology; 2005 Jun; 65(6):1152-6. PubMed ID: 15913718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The present possibilities for routine use of blood-saving measures from the anesthesiologic point of view--theoretical basis and clinical practice. I. Potential risks of homologous transfusion; normovolemic hemodilution].
    Singbartl G; Schleinzer W
    Anaesthesiol Reanim; 1994; 19 Suppl():4-10. PubMed ID: 8148016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to homologous blood transfusion.
    Tawes RL
    Semin Vasc Surg; 1994 Jun; 7(2):72-5. PubMed ID: 8087283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.
    Spence RK
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of autologous transfusion for radical prostatectomy].
    Sugino S; Shichinohe Y; Kuroda H; Tsuchiya S; Tsunoda K; Shindoh J; Enami N; Namiki A
    Masui; 2005 Jul; 54(7):762-6. PubMed ID: 16026057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks, benefits, alternatives and indications of allogenic blood transfusions.
    Madjdpour C; Heindl V; Spahn DR
    Minerva Anestesiol; 2006 May; 72(5):283-98. PubMed ID: 16675937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection.
    Jarnagin WR; Gonen M; Maithel SK; Fong Y; D'Angelica MI; Dematteo RP; Grant F; Wuest D; Kundu K; Blumgart LH; Fischer M
    Ann Surg; 2008 Sep; 248(3):360-9. PubMed ID: 18791356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery.
    Habler O; Schwenzer K; Zimmer K; Prager M; König U; Oppenrieder K; Pape A; Steinkraus E; Reither A; Buchrot A; Zwissler B
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):467-75. PubMed ID: 15183411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Artificial oxygen carriers as an alternative to red blood cell transfusion].
    Habler O; Pape A; Meier J; Zwissler B
    Anaesthesist; 2005 Aug; 54(8):741-54. PubMed ID: 16021390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do we treat life-threatening anemia in a Jehovah's Witness patient?
    Posluszny JA; Napolitano LM
    Transfusion; 2014 Dec; 54(12):3026-34. PubMed ID: 25330835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
    Faris PM; Ritter MA
    Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
    Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
    Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospectus. Future trends in transfusion.
    Manner PA; Rubash HE; Herndon JH
    Clin Orthop Relat Res; 1998 Dec; (357):101-15. PubMed ID: 9917706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.